Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat
about
Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendationsHepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawalReview article: autoimmune hepatitis -- current management and challenges.Identification of risk factors for hepatitis B and C in Peshawar, Pakistan.Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcomeOccult HBV infection in the oncohematological setting.Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma.Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen negative patients with hematological malignancies.Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection.Molecular analysis of the interspousal transmission of hepatitis B virus in two Japanese patients who acquired fulminant hepatitis B after 50 and 49 years of marriage.Late reactivation of occult hepatitis B virus infection in a patient with chronic lymphocytic leukemia after rituximab and fludarabine-based regimen.Occult hepatitis B virus infection in immunized children born to carrier mothers.
P2860
Q26784247-AAA6D056-514B-4EE5-ACC3-174A64474B9AQ26995814-9AC1B587-FC6E-4683-ADCE-04537958DCF8Q34369116-85C48CC3-BC3D-420E-B6A6-4EA35ADF32FEQ35982168-6C7A0FEB-B763-4EBB-8B29-0676843ECE80Q37266330-10AF2B6E-C9C5-4C99-BEC4-29F45C69E3ACQ38807875-C666AB37-867C-4C98-8637-F6FAD6EDF035Q40097433-77473B06-7603-47AD-9C55-B8172A823EE3Q41252998-3DB51C95-29DF-4214-8975-80C9166B0615Q41527993-6FE2C8B4-1D90-4AF2-BBE8-D788226F18F2Q42199419-985194EE-EBD7-4DE5-9AB0-5EE8E83C3118Q45345680-98FE1E3A-9BB2-4185-8E8B-AD2B60CA6D46Q53551944-3C756A75-3F4E-4E20-BA7C-FA57DCF938B3
P2860
Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis B virus reactivation ...... nosuppression: A hidden threat
@en
Hepatitis B virus reactivation ...... osuppression: A hidden threat.
@nl
type
label
Hepatitis B virus reactivation ...... nosuppression: A hidden threat
@en
Hepatitis B virus reactivation ...... osuppression: A hidden threat.
@nl
prefLabel
Hepatitis B virus reactivation ...... nosuppression: A hidden threat
@en
Hepatitis B virus reactivation ...... osuppression: A hidden threat.
@nl
P2093
P2860
P356
P1476
Hepatitis B virus reactivation ...... nosuppression: A hidden threat
@en
P2093
Aggelos Stefos
Alexandros Sarantopoulos
Asterios Saitis
George N Dalekos
Kalliopi Zachou
Nikolaos K Gatselis
Panagiota Boura
Stella Gabeta
Themistoklis Vassiliadis
P2860
P304
P356
10.4254/WJH.V5.I7.387
P577
2013-07-01T00:00:00Z